|
October
2009 |
|
|
|
 |
20/10/2009 |
Patient Power and the Role of Biotech
in Europe
 |
|
|
06/10/2009 |
Telomeres: where the end is just the beginning - Three share Nobel
Prize for groundbreaking genetic discovery
|
|
June
2009 |
|
|
|
11/06/2009 |
EU
leaders commit to more action on Rare Diseases: “Europe and its rare
disease patients will benefit,” say stakeholders |
|
May
2009 |
|
|
|
20/05/2009 |
Changing the EU Public Health Dynamic: Better science, regulation
and access policies to deliver biopharmaceutical innovation for
Europe’s citizens |
|
April
2009 |
|
|
|
22/04/2009 |
Promoting Patients’ Rights in the
EU
|
|
|
21/04/2009 |
“Patients First,” says biotech
industry in new Healthcare Manifesto
|
|
March
2009 |
|
|
|
04/03/2009 |
Biotechnology is the key to combat
rare diseases
|
|
February 2009 |
|
|
|
04/02/2009 |
EuropaBio welcomes World Cancer Day 2009
|
|
December
2008 |
|
|
|
15/12/2008 |
Biotech industry welcomes European Commission’s pharmaceutical
package which will ensure that Europe’s patients continue to benefit
from safe, innovative and accessible medicines
|
|
|
10/12/2008 |
EuropaBio congratulates the 2008 winners of the Nobel
Prize for Medicine
|
|
November
2008 |
|
|
|
18/11/2008 |
EuropaBio welcomes first-ever European Antibiotic Awareness Day
|
|
|
13/11/2008 |
EuropaBio and EBE congratulate EU
leaders on the
Commission Communication on Rare Diseases and calls for European
action to turn principles and proposals into reality
|
|
|
06/11/2008 |
EuropaBio acknowledges need for review of the
laboratory animal protection Directive but calls for a reduction of
the bureaucratic burden the Directive will place on SMEs
|
|
October
2008 |
|
|
|
02/10/2008 |
EuropaBio welcomes the outcomes of the High Level Pharmaceutical
Forum and calls for a seamless policy framework to support patients
and research
|
|
September
2008 |
|
|
|
24/09/2008 |
EuropaBio welcomes European Patients’ Forum Patients’ Manifesto
|
|
July
2008 |
|
|
|
03/07/2008 |
EuropaBio supports Commission action to simplify regulations on
variations to marketing authorisations
|
|
March 2008 |
|
|
|
03/03/2008 |
SMEs are THE new paradigm for
innovation in healthcare
|
|
February 2008 |
|
|
|
29/02/2008 |
EuropaBio supports patient action for Rare Disease Day
EuropaBio Briefing -
Rare Diseases:
Europe's Challenges |
|
|
14/02/2008 |
Biotech
industry supports common security market for Bio-Preparedness
|
|
December 2007 |
|
|
|
07/12/2007 |
|
European Court of Justice to rule on Lithuania’s failure to
abide by European law on biosimilars
>document:
EN
|
|
|
November 2007 |
|
|
|
28/11/2007 |
|
EU-US
authorities to harmonize medicines approval process
>document:
EN |
|
|
|
21/11/2007 |
|
Portuguese
Presidency promotes the EU’s commitment to healthcare
biotechnology
>document:
EN |
|
|
|
14/11/2007 |
|
Italian field
trials results suppressed by the government
>document:
EN |
|
|
October 2007 |
|
|
|
19/10/2007 |
|
Misuse of cost containment policies threatens
patient access to Orphan Medicines
>document:
EN |
|
|
|
19/10/2007 |
|
EPPOSI Press release -
Medicines for the few – How can society better
understand the reality of medicines for rare diseases?
>document:
EN |
|
|
|
12/10/2007 |
|
Spain prevents automatic
substitution of biological medicines, providing clarity for
pharmacists and patients
>document:
EN |
|
|
|
04/10/2007 |
|
Future of Clinical Trials in Europe: Biotech
industry’s keys for change
>document:
EN |
|
|
September
2007 |
|
|
|
14/09/2007 |
|
European Commission conference
underlines value of orphan drug development
>documents:
EN |
|
|
July 2007 |
|
|
|
13/07/2007 |
EuropaBio welcomes new EMEA
technical document on biosimilars
> documents :
EN |
|
May 2007 |
|
|
|
31/05/2007 |
European framework adopted today on
“Advanced Therapies” will allow European-wide access to a new
generation of treatments
> documents
:
EN
|
|
|
09/05/2007 |
EuropaBio calls for six standards
to value innovation in healthcare
> documents
:
EN
|
|
April 2007 |
|
|
|
25/04/2007 |
EuropaBio congratulates European Parliament on big step towards
Advanced Therapies Regulation
> documents
:
EN
|
|
|
10/04/2007 |
Europe loses as trialogue negotiations on proposed Advanced
Therapies Regulation fail
> documents
:
EN
|
|
March 2007 |
|
|
|
23/03/2007 |
BioVision calls for the approval of the EU Regulation
on Advanced Therapies
> documents
:
EN
|
|
|
14/03/2007 |
New studies show the benefits of biotech healthcare
innovation for patients and society
> documents
:
EN
|
|
|
09/03/2007 |
Companies researching and developing treatments for
rare diseases welcome draft Commission guideline providing legal
certainty on market exclusivity for Orphan Medicines
> documents :
EN |
|
February 2007 |
|
|
|
28/02/2007 |
EU Regulation Urgently Needed!
European Patients are Waiting for the Next Generation of Medical
Treatments - EPPOSI Press Release
> documents
:
EN |
|
|
27/02/2007 |
EU Institutions Press for Early Adoption of Advanced
Therapies Regulation
> documents
:
EN
|
|
|
21/02/2007 |
Bioindustry welcomes new French legislation covering
biosimilar medicines
> documents
:
EN |
|
January 2007 |
|
|
|
30/01/2007 |
Biotech industry welcomes outcome of
Parliament’s ENVI vote on Advanced Therapies Medicinal Products
Regulation
> documents
:
EN
|
|
|
24/01/2007 |
EuropaBio supports patients, science and industry's call to value
healthcare innovation
> statement:
EN
|
|
December
2006 |
|
|
|
18/12/2006 |
EPAA Press Release - EuropaBio is a
founding member of EPAA – A platform for Alternative Approaches to
Animal Testing
> documents :
EN |
|
November 2006 |
|
|
|
10/11/06 |
Biotech Industry Welcomes WHO
Initiative on Naming of Biologicals including Biosimilar Medicines
> documents :
EN
|
|
October 2006 |
|
|
|
27/10/06 |
Millions of Europeans suffer from
Rare Diseases–Why are they not higher on the healthcare agenda?
> documents :
EN
|
|
September 2006 |
|
|
|
28/09/06 |
Biotech industry calls for a
patient-centered healthcare system in Europe
> documents :EN |
|
June 2006 |
|
|
|
27/06/06 |
Orphan Medicines Regulation for rare diseases on the
road to success
> documents :
EN |
|
|
21/06/06 |
New action programme to accelerate
research into alternative approaches to animal testing
> documents :
EN
|
|
May 2006 |
|
|
|
30/05/06 |
Chairman of EuropaBio Healthcare
Council calls for effective and timely patient access to innovative
medicines: beyond the subsidiarity principle
> documents :
EN |
|
December
2005 |
|
|
|
20/12/05 |
European Platform for Patients Organisations, Science
and Industry appoints new head
> documents :
EN |
|
|
15/12/05 |
EMEA opens arms to small
and medium sized biotech companies
> documents :
EN
|
|
|
12/12/05 |
New guidelines for development and
approval of biosimilars move closer
>
documents :
EN |
|
November 2005 |
|
|
|
16/11/05 |
Advanced therapies: Biotech industry welcomes new rules
>
documents :
EN |
|
|
09/11/05 |
European biotech industry debates new Advanced Therapies Regulation
together with all stakeholders
>
documents :
EN |
|
|
07/11/05 |
Key
Industry Sectors Sign up to further Refine, Reduce and Replace the
Use of Animals in Testing
> documents
:
EN |
|
14/07/2005 |
|
|
EuropaBio supports EFPIA's
position on paediatric medicines
|
|
March 2005 |
|
|
04/03/2005 |
|
|
Room for improved application of Orphan Medicines rules in
Europe, says biotech industry
documents
:
EN
|
|
|
February 2005 |
|
|
10/02/2005 |
|
|
Bioimpact:
Biotechnology for Patients - Presentation of the results of Bioimpact -
first scientific study on the impact of biotechnology-derived medicines on
the quality of life and life expectancy of patients
documents
:
EN
FR
NL |
|
|
December
2004 |
|
|
10/12/2004 |
|
|
Rare disease patients treated
unequally in Europe, says study
documents :
EN
|
|
April 2004 |
|
|
30/04/2004 |
|
|
EU Commission publishes recommendations
on medical genetic testing -
documents :
EN
|
|
January 2004 |
|
|
|
23/01/2004 |
|
|
First ever report on regenerative
medicine in Europe
-documents :
EN
|
|
December 2003 |
|
|
17/12/2003 |
|
|
Europe is first to rule for biosimilar
products -
documents :
EN
|
|
16/12/2003 |
|
|
Parliament approves new safety rules for
human cell and tissues -
documents :
EN
|
|
12/12/2003 |
|
|
Industry strongly supports European
Parliament focus on safe human cell and tissue handling
-
documents :
EN
|
|
November 2003 |
|
|
27/11/2003 |
|
|
New Pharma rules veer off piste
- documents :
EN
|
|
14/11/2003 |
|
|
Biotech industry urges Ministers and MEPs
to back guidelines on embryonic stem cells -
documents :
EN
|
|
|
03/11/2003 |
|
|
Imminent vote on first EU wide standards
for human tissue and cells -
documents :
EN
|
|
October 2003 |
|
|
01/10/2003 |
|
|
EuropaBio supports study into cost of
orphan medicines -
documents :
EN
|
|
September 2003 |
|
|
30/09/2003 |
|
|
EuropaBio welcomes new code on medicine,
but reservations on biosimilar medicines remain -
documents :
EN
|
FR
|
DE
|
|
July 2003 |
|
|
1/07/2003 |
|
|
Pharmaceutical growth and competitiveness
will not happen without biotech -
documents :
EN
|
|
December 2002 |
|
|
|
03/12/2002 |
|
|
Patients, industry, scientists,
regulators and the public agree that treatment for rare
diseases is a European priority
documents :
EN
|
FR
|
DE
|
|
November 2001 |
|
|
29/11/2001 |
|
|
European Parliament rejects Fiori report:
EuropaBio confirms its willingness to contribute to
future debates on genetics and medicine
|
|
documents :
EN
|
|
July 2000 |
|
|
17/07/2000 |
|
|
Interdisciplinary Forum Breaks Down
Barriers to New Treatments for Rare Diseases
documents :
EN
|
|
|
|
June 2000 |
|
|
13/06/2000 |
|
|
European BioIndustries publish
Information Paper on Gene Therapy
documents :
EN
|
Healthcare
Biotech Press Releases Archive 1999-2009